Moderna
MRNA
$108.85
Share price
0.89%
Change (1 day)
-21.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $4.57 B
According to Moderna 's latest financial reports the company's total liabilities are $4.57 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Moderna - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $4.57 B | -32.12% |
| 2022-12-31 | $6.73 B | -36% |
| 2021-12-31 | $10.52 B | 120.35% |
| 2020-12-31 | $4.77 B | 1051.92% |
| 2019-12-31 | $0.41 B | -4% |
| 2018-12-31 | $0.43 B | -5.94% |
| 2017-12-31 | $0.45 B | -20.18% |
| 2016-12-31 | $0.57 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 2,060.63% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 1,063.50% | 🇨🇭 Switzerland |
 Merck MRK | $69.04 B | 1,410.06% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $9.48 M | -99.79% | 🇺🇸 USA |
 Athersys ATHX | $43.82 M | -99.04% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.05 B | -11.41% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.45 B | -90.10% | 🇺🇸 USA |